Company | British American Tobacco launches "Vapers Deserve Better" campaign in the UK, calling for mandatory testing and retail licensing

Sep.29.2025
Company | British American Tobacco launches "Vapers Deserve Better" campaign in the UK, calling for mandatory testing and retail licensing
British American Tobacco UK (BAT UK) announced the launch of its "Vapers Deserve Better" campaign this week, emphasizing the need for a responsible regulatory framework to combat non-compliant operators who ignore regulations and quality standards. The campaign advocates for mandatory pre-market testing, a national retail licensing system, and stricter penalties for offenders.

Key points:

 

·Goals and Industry Status: In 2019, the UK set a target for a smoke-free future by 2030, with British American Tobacco supporting and viewing e-cigarettes as key. However, the e-cigarette industry faces issues such as violations by practitioners and uneven product quality, requiring responsible leadership. 

·Corporate Actions and Demands: British American Tobacco has launched the "e-cigarette users deserve better" campaign, urging the Tobacco and E-cigarette Act to include mandatory pre-market testing, a retail licensing system, and penalties for violators. 

·Public Awareness Data: 67% of the British public believes that e-cigarettes are as harmful as or more harmful than smoking; 53% are unaware of the NHS guidance that states e-cigarettes are less harmful than smoking, with the misconception dropping to 52% after being informed. 

·Potential Risks and Policy Impacts: 10% of surveyed e-cigarette users are considering relapsing, potentially affecting up to 560,000 people nationwide and leading to a rise in smoking rates for the first time since 1974; the government's proposed ban on nicotine product advertising may reduce awareness of smoke-free alternatives and impact smoking cessation efforts.

 


 

2Firsts, September 29, 2025 - According to Politics Home, Asli Ertonguc, the Western Europe Regional Director of British American Tobacco UK, has stated that BAT supports the smoke-free society goal in the UK, but not all e-cigarette products meet the same standards of quality. The industry is facing threats from irresponsible practitioners who disregard regulatory requirements, ignore basic quality standards, and fail to fulfill product management responsibilities.

 

This week, British American Tobacco launched a new campaign called "Vapers Deserve Better." This initiative is aimed at addressing the challenges facing the industry and calling for the implementation of improved and enforceable regulations.

 

Currently, the Tobacco and Vapes Bill is still under parliamentary review, and British American Tobacco believes there is no reason to adopt a stance of inaction at this time.

 

Specifically, British American Tobacco is calling for the implementation of a mandatory pre-market testing mechanism, immediate promotion of retail licensing systems, and stricter penalties for practitioners who believe regulations do not apply to them.

 

British American Tobacco has clearly stated that if these measures are not taken, the existing progress that the UK has made in building a smoke-free society will face the risk of regression.

 

A study conducted by the polling organization Obsurvant revealed that two-thirds (67%) of the surveyed British public believe that the harm of e-cigarettes is equivalent to, or even greater than, smoking. Despite clear statements from the National Health Service (NHS), Public Health England, and the Office for Health Improvement and Disparities that "the risks of e-cigarettes are only a small fraction of the risks of smoking," the public still holds the aforementioned belief. Of concern is that among surveyed smokers, one-sixth of them and over half of e-cigarette users also agree with this viewpoint.

 

This cognitive bias poses a real risk. The study found that 10% of surveyed e-cigarette users in the UK are actively considering starting smoking again. If this proportion is representative of all e-cigarette users in the UK, then the corresponding number would be approximately 560,000 people. If this cognitive bias continues, the smoking rate in the UK may increase for the first time since records began in 1974.

 

For many people, the results of this investigation may not come as a surprise. The e-cigarette industry has often faced negative consequences due to such "poor quality products.

 

It may come as a surprise that more than half (53%) of the respondents in a survey were not aware of the clear guidance from the UK National Health Service that "nicotine e-cigarettes are not completely risk-free, but far less harmful than smoking". After being informed of this information, the proportion of those who believed "e-cigarettes are as harmful as smoking" decreased from 67% to 52%.

 

As it stands, the proposed legislation by the UK government may further reinforce the above-mentioned misconception among the public. An example of this is the proposed ban on nicotine product advertisements.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Elf Bar Vape Explosion and Amputation Claim Spurs Coverage Suit, U.S. Insurer MUSIC Seeks Ruling It Owes No Duty to Defend or Indemnify Distributor i5
Elf Bar Vape Explosion and Amputation Claim Spurs Coverage Suit, U.S. Insurer MUSIC Seeks Ruling It Owes No Duty to Defend or Indemnify Distributor i5
Mesa Underwriters Specialty Insurance Company has asked a federal court in Washington to declare that it has no duty to defend or indemnify vape distributor i5 Distribution in a product liability case involving an Elf Bar BC5000. The plaintiff alleges that the disposable vape caught fire and exploded in his pocket, causing severe burns and ultimately requiring an above-the-knee amputation of his left leg. MUSIC is relying on a tobacco, nicotine or nicotine replacement products exclusion and a premises limitation endorsement. The court has not ruled on the coverage dispute.
News
Sep.10
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
South Korean Lawmaker Jeong Jin-wook Pushes Synthetic Nicotine Vape Probe, Highlighting Supply Chain and Tax Concerns
South Korean Lawmaker Jeong Jin-wook Pushes Synthetic Nicotine Vape Probe, Highlighting Supply Chain and Tax Concerns
South Korean lawmaker Jeong Jin-wook has again called for stronger government action against liquid synthetic nicotine vape manufacturers and sellers, alleging that some businesses may have avoided regulation through product labeling changes and corporate restructuring. According to Newsworks, JNILBO and other Korean reports, Jeong has held his third press conference on the issue, calling for a government-wide investigation. The dispute involves whether synthetic nicotine products should fall under tobacco regulations, tax implications and supply-chain transparency. South Korean government agencies have previously said some estimates of potential tax losses cannot be verified due to limited sales data.
Jul.27
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
Philippine Local Governments Urge Marcos to Prioritize Smoke- and Vape-Free Bill
Philippine Local Governments Urge Marcos to Prioritize Smoke- and Vape-Free Bill
The League of Municipalities of the Philippines (LMP) has urged President Ferdinand Marcos Jr. to prioritize the Smoke- and Vape-Free Bill, seeking a nationwide legal framework for tobacco and vape regulation. Local government leaders said national legislation would help standardize enforcement and strengthen public health measures. The proposal remains at the advocacy stage and has not yet become law.
Jul.29
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23